Matinas BioPharma (MTNB)

• Market cap: $3.87M
• 1 day: -14.93%
• 5 days: -23.23%
• 1 month: 11.85%
• 3 months: 1.51%
• 6 months: -22.06%
• Year to date: -2.58%
• 1 year: -32.88%
• 5 years: -98.56%
• 10 years: -99.69%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Employees: 2